These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 7169568

  • 1. [Immunotherapy of non-resectable or recurrent cancer with a streptococcal preparation, OK-432--changes in immunologic parameters and evaluation of the periods of survival following intradermal and intramuscular injections].
    Hanaue H, Nomoto S, Seto A, Kimura T, Kutsuna T, Takeuchi T, Yoshizaki S.
    Nihon Gan Chiryo Gakkai Shi; 1982 Dec 20; 17(8):1975-85. PubMed ID: 7169568
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical trial of oral immunotherapy with streptococcal preparation OK 432 on gastric cancer].
    Nio Y, Ohgaki K, Henmi K, Kan N, Inamoto T, Tsuchitani T, Kodama H, Tobe T.
    Nihon Gan Chiryo Gakkai Shi; 1982 Apr 20; 17(3):728-34. PubMed ID: 6752308
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)].
    Shiraishi T, Nio Y, Imai S, Tsubono M, Morimoto H, Tseng CC, Tobe T, Tanaka T, Kitamura O, Sakanashi S.
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr 20; 25(4):799-811. PubMed ID: 2196311
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of malignant ascites. II. Immunological studies on disappearance of ascites by intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)].
    Katano M.
    Fukuoka Igaku Zasshi; 1981 Oct 20; 72(10):543-55. PubMed ID: 7327499
    [No Abstract] [Full Text] [Related]

  • 11. [Immunohistological studies of the skin at the injection site of cases receiving the streptococcal agent OK-432].
    Hanaue H, Kurosawa T, Miyakawa S, Horie F, Nemoto A, Yamoto H, Nishimura S, Tsuchiya H, Miura S, Asagoe T.
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec 20; 20(10):2271-8. PubMed ID: 3879494
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of T-cell lymphoma with immunotherapy of OK-432--a case report (author's transl)].
    Nakayama S, Tsuji K, Kitajima K, Ueno K, Hoshino T.
    Rinsho Ketsueki; 1980 Jan 20; 21(1):66-72. PubMed ID: 6966340
    [No Abstract] [Full Text] [Related]

  • 18. Blastogenic responses of human lymphocytes to a streptococcal preparation OK-432 and its fractions.
    Tanaka T, Kaneko Y, Haba F, Katsuta S, Tsutsui K, Tamaki S, Chen DR, Suzuki S, Ueda R, Yamamoto A.
    J Clin Lab Immunol; 1989 Feb 20; 28(2):91-6. PubMed ID: 2787407
    [Abstract] [Full Text] [Related]

  • 19. Clinical value of immunotherapy with the streptococcal preparation OK-432 in non-small cell lung cancer.
    Watanabe Y, Iwa T.
    J Biol Response Mod; 1987 Apr 20; 6(2):169-80. PubMed ID: 3585412
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of various administration routes of the streptococcal preparation, OK-432, with regard to their in vivo effect by lymphocytes proliferation assay].
    Kimura Y, Toki H, Okabe K, Fujii M, Tamai M.
    Gan To Kagaku Ryoho; 1986 Jan 20; 13(1):95-100. PubMed ID: 3942400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.